Several three-dimensional cell culture systems are currently available to create liver organoids. In gneral, these systems display better physiologic and metabolic aspects of intact liver tissue compared with two-dimensional culture systems. However, none reliably mimic human liver development, including parallel formation of hepatocyte and cholangiocyte anatomical structures. Here, we show that human fetal liver progenitor cells self-assembled inside acellular liver extracellular matrix scaffolds to form three-dimensional liver organoids that recapitulated several aspects of hepatobiliary organogenesis and resulted in concomitant formation of progressively more differentiated hepatocytes and bile duct structures. The duct morphogenesis process was interrupted by inhibiting Notch signaling, in an attempt to create a liver developmental disease model with a similar phenotype to Alagille syndrome. Conclusion: In the current study, we created an in vitro model of human liver development and disease, physiology, and metabolism, supported by liver extracellular matrix substrata; we envision that it will be used in the future to study mechanisms of hepatic and biliary development and for disease modeling and drug screening. (Hepatology 2018;67:750-761).
Several three-dimensional cell culture systems are currently available to create liver organoids. In gneral, these systems display better physiologic and metabolic aspects of intact liver tissue compared with two-dimensional culture systems. However, none reliably mimic humanliver development, including parallel formation of hepatocyte and cholangiocyte anatomical structures. Here, we show that human fetal liver progenitor cells self-assembled inside acellular liver extracellular matrix scaffolds to form three-dimensional liver organoids that recapitulated several aspects of hepatobiliary organogenesis and resulted in concomitant formation of progressively more differentiated hepatocytes and bile duct structures. The duct morphogenesis process was interrupted by inhibiting Notch signaling, in an attempt to create a liver developmental disease model with a similar phenotype to Alagille syndrome. Conclusion: In the current study, we created an in vitro model of humanliver development and disease, physiology, and metabolism, supported by liver extracellular matrix substrata; we envision that it will be used in the future to study mechanisms of hepatic and biliary development and for disease modeling and drug screening. (Hepatology 2018;67:750-761).
Authors: Pedro M Baptista; Giuseppe Orlando; Sayed-Hadi Mirmalek-Sani; Mohummad Siddiqui; Anthony Atala; Shay Soker Journal: Conf Proc IEEE Eng Med Biol Soc Date: 2009
Authors: Claire N Medine; Baltasar Lucendo-Villarin; Christopher Storck; Faye Wang; Dagmara Szkolnicka; Ferdous Khan; Salvatore Pernagallo; James R Black; Howard M Marriage; James A Ross; Mark Bradley; John P Iredale; Oliver Flint; David C Hay Journal: Stem Cells Transl Med Date: 2013-06-11 Impact factor: 6.940
Authors: Yonatan R Lewis-Israeli; Brett D Volmert; Mitchell A Gabalski; Amanda R Huang; Aitor Aguirre Journal: J Vis Exp Date: 2021-09-15 Impact factor: 1.424
Authors: Matthew Brovold; Joana I Almeida; Iris Pla-Palacín; Pilar Sainz-Arnal; Natalia Sánchez-Romero; Jesus J Rivas; Helen Almeida; Pablo Royo Dachary; Trinidad Serrano-Aulló; Shay Soker; Pedro M Baptista Journal: Adv Exp Med Biol Date: 2018 Impact factor: 2.622
Authors: Saloomeh Mokhtari; Pedro M Baptista; Dipen A Vyas; Charles Jordan Freeman; Emma Moran; Matthew Brovold; Guillermo A Llamazares; Zanneta Lamar; Christopher D Porada; Shay Soker; Graça Almeida-Porada Journal: Stem Cells Transl Med Date: 2018-02-23 Impact factor: 6.940